Clinical Equivalence Study of Mometasone Nasal Spray
Public ClinicalTrials.gov record NCT01850823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Watson Laboratories, Inc) with NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Study identification
- NCT ID
- NCT01850823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 880 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2013 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Aug 19, 2020
2013
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator site 18 | Stockbridge | Georgia | — | — |
| Investigator site 1 | Louisville | Kentucky | — | — |
| Investigator site 3 | Bethesda | Maryland | — | — |
| Investigator Site 19 | Minneapolis | Minnesota | — | — |
| Investigator Site 24 | St Louis | Missouri | — | — |
| Investigator site 22 | Bellevue | Nebraska | — | — |
| Investigator Site 23 | Skillman | New Jersey | — | — |
| Investigator site 2 | Corning | New York | — | — |
| Investigator site 9 | High Point | North Carolina | — | — |
| Investigator site 20 | Raleigh | North Carolina | — | — |
| Investigator site 25 | Cincinnati | Ohio | — | — |
| Investigator site 21 | Sylvania | Ohio | — | — |
| Investigator site 16 | Spartanburg | South Carolina | — | — |
| Investigator Site 10 | Austin | Texas | — | — |
| Investigator Site 12 | Austin | Texas | — | — |
| Investigator site 6 | Austin | Texas | — | — |
| Investigator Site 11 | Kerrville | Texas | — | — |
| Investigator Site 7 | New Braunfels | Texas | — | — |
| Investigator Site 13 | San Antonio | Texas | — | — |
| Investigator site 14 | San Antonio | Texas | — | — |
| Investigator site 5 | San Antonio | Texas | — | — |
| Investigator site 8 | San Antonio | Texas | — | — |
| Investigator site 4 | Waco | Texas | — | — |
| Investigator Site 15 | Draper | Utah | — | — |
| Investigator Site 17 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01850823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01850823 live on ClinicalTrials.gov.